Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

NCT03020303 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.

NCT NCT03020303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03020303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
Lead sponsor
Hamilton Health Sciences Corporation
Phase
Phase 3
Overall status
Completed
Start date
July 7, 2017
Completion date
March 14, 2025
Enrollment
2,538 (actual)
Sites
141

Conditions

As the registry lists them; a condition with its own page is linked.

endstage renal disease